Skip to content
PaperFren

Innate immunity

Which sensor starts IFN against SARS-CoV-2 in lung cells?

Yin X, Riva L, Pu Y, et al. · Cell reports · 2021

Open access · cc by · source: Europe PMC

SARS-CoV-2 triggers delayed IFN mainly via MDA5/LGP2 sensing of viral intermediates, with IRF3/IRF5/NF-κB p65 as key TFs.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

  • MDA5/LGP2 dominate IFN induction to SARS-CoV-2 in lung epithelial cells.

    Sensor screens showed MDA5 and LGP2 primarily regulate IFN induction to SARS-CoV-2, with delayed IFN and IRF3/IRF5/NF-κB p65 as key transcription factors.

    Evidence for the claim as stated.

  • Interferon programs reshape host gene expression during viral defense.

    Host-defense work shows interferon-mediated down-regulation as part of antiviral control—effector-layer evidence beside sensor identity.

    Scope note — IFN effector programs ≠ which sensor starts SARS-CoV-2 IFN in epithelium

    Limits the claim's scope: a different population, assay, or outcome.

  • TIR-domain architecture participates in innate association/signaling logic.

    TIR-domain association findings add receptor-proximal innate signaling context to nucleic-acid sensor → IFN pathways.

    Scope note — TIR-domain study ≠ MDA5 SARS-CoV-2 screen

    Limits the claim's scope: a different population, assay, or outcome.

  • Which sensor fires in one epithelial infection model does not settle interferon effector strategies across all viruses or tissues.

    Evidence for the claim as stated.

Open questions

Tensions this paper is part of

From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.

Study at a glance

Design
Animal / in-vitro — Lung epithelial infection + RNA-sensor/TF screens
N
N=16 · 16 putative sensors screened
Population
Lung epithelial cells infected with SARS-CoV-2
Outcome
Sensors/TFs governing IFN induction

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Which sensor starts IFN against SARS-CoV-2 in lung cells?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

16 sensors screened.

By screening 16 putative sensors involved in sensing of RNA virus infection, we found that MDA5 and LGP2 primarily regulate IFN induction in response to SARS-CoV-2 infection.

Delayed IFN in lung epithelium.

Here, we find that SARS-CoV-2 replication induces a delayed interferon (IFN) response in lung epithelial cells.
Read passages in the original paper

Key findings

Delayed IFN; MDA5 and LGP2 primary sensors; viral intermediates activate MDA5 pathway; IRF3, IRF5, NF-κB/p65 key TFs.

Methodology

Infected lung epithelial cells and screened candidate RNA sensors and transcription factors for IFN induction.

Limitations

In-vitro epithelial circuits may differ from whole-lung immune networks in patients.

Related papers in this topic

Same topic cluster — not a recommendation engine.